Loading...
Loading...
Browse all stories on DeepNewz
VisitPublic response to DOJ lawsuit against CVS for opioid prescriptions by end of 2025
Widespread support for DOJ • 25%
Mixed reactions • 25%
Widespread support for CVS • 25%
Indifference • 25%
Public opinion polls, major news outlets reporting on public sentiment
DOJ Sues CVS Health Corp. for Knowingly Filling Illegal Opioid Prescriptions Amid Nationwide Crisis
Dec 18, 2024, 11:45 PM
The U.S. Department of Justice has filed a lawsuit against CVS Health Corp., alleging that the pharmacy chain knowingly filled and billed federal health insurance programs for illegal opioid prescriptions, contributing to the nationwide opioid addiction and overdose crisis. The lawsuit claims that from October 17, 2013, to the present, CVS filled prescriptions for controlled substances that lacked a legitimate medical purpose, including dangerous quantities of opioids, early fills, and 'trinity' prescriptions, which combine an opioid, a benzodiazepine, and a muscle relaxant. The DOJ alleges that CVS ignored red flags and evidence from its own pharmacists and internal data, prioritizing corporate profits over patient safety. The lawsuit also accuses CVS of filling prescriptions from prescribers known to be engaged in 'pill mill practices,' where large numbers of controlled substance prescriptions are issued without a medical purpose. CVS, operating over 9,000 pharmacies across the U.S., has stated that it strongly disagrees with the allegations and will defend itself vigorously against the DOJ lawsuit.
View original story
CVS found liable • 25%
CVS settles • 25%
CVS not liable • 25%
Case dismissed • 25%
CVS found guilty • 25%
Ongoing litigation • 25%
CVS found liable • 25%
CVS settles • 25%
Case dismissed • 25%
Other outcome • 25%
Walgreens • 25%
Rite Aid • 25%
Walmart • 25%
None of the above • 25%
Public apology and reform announcement • 25%
Focus on new business initiatives • 25%
Legal defense and appeal • 25%
No public response • 25%
Announce internal policy changes • 25%
Face additional lawsuits • 25%
No significant actions taken • 25%
Announce new partnerships or acquisitions • 25%
No significant impact • 25%
Major financial penalties • 25%
Minor financial penalties • 25%
Severe financial penalties • 25%